Who is affected and who holds the decision right?
5 min read
Lesson objectives
- Map analyst, payer, provider and patient roles against the delegation instrument.
Please sign in to use all the tools
Once you sign in, the reading tools are yours: larger or smaller text, typeface, line spacing, focus mode, highlighting and bold, and notes saved to your account and gathered in My study.
An economic brief can be arithmetically sound and still stall because the decision owner is unclear or a group bears a burden the team never heard about. A stakeholder map is an analytical tool, not a ceremonial invitation list. Distinguish people affected by the policy, people supplying evidence or experience, people implementing the change, and the body formally authorized to approve it. One person may have several roles, but attending a meeting does not confer approval authority. WHO's evidence-informed policy approach involves decision makers, researchers, civil society, patients and professionals while adapting evidence to context. The actual chain of authority must come from the relevant institution, not from this training guide.
Draw the path of this decision rather than the entire organization chart. Who requested the analysis? Who sets scope and budget? Who reviews clinical safety or legal issues if needed? Who signs the decision? Who implements and monitors the change? For each stage label the role recommends, approves, implements, consulted, or informed. Do not label someone an approver merely because they know the data best. Approval may be divided: a specialist committee recommends, finance checks the ceiling, and a statutory authority issues the decision. If that chain has not been verified, mark it unverified and ask the institution before presenting a recommendation as if it were effective policy.
After authority, examine the effects on people. In a fictional chronic-disease follow-up service, a purchaser hopes to reduce unplanned admissions, a clinician needs a clear referral route, and a patient may face a long trip or need a phone. Administrative staff may spend extra time confirming appointments. For each group, record a possible benefit, burden and piece of information that analysts lack. A patient's report of travel costs does not replace cost data, but can reveal an omitted household cost. A clinician's judgment about eligibility does not automatically establish the magnitude of an intervention effect; that requires suitable measurement or evidence.
Administrative power and degree of impact are different. The purchaser may have authority without bearing travel or waiting costs; patients may struggle to attend meetings even though the decision matters greatly to them. Do not exclude a group for having little influence. Use two axes: influence on implementation and exposure to consequences. Choose a way to hear each group that addresses barriers, such as a short interview in accessible language or review by a trusted representative while protecting privacy. The map is meant to test assumptions and explain risks, not reduce a group's voice. Record who was not heard and why rather than calling a limited consultation consensus.
Include a conflict-of-interest field. A provider may offer valuable data while benefiting financially from an expanded contract. Its data are not automatically invalid, but check their source and definitions, seek independent verification when possible, and disclose the interest in the brief. Patients can also have differing interests: a digital service may improve access for people with reliable connections and worsen it for others. Do not treat them as one voice. If a group is absent from the data, show that as a decision risk rather than replacing it with an apparently precise overall average.
The map should change the analysis. If patients say transport is a barrier, add travel money and time to the household perspective and test whether option rankings change. If scheduling staff say the proposal requires two more hours daily, request a shift roster and cost the work instead of writing only ‘feasible’. If specialists disagree about safety or legality, pause that claim and seek the appropriate review. Deliberation then affects model assumptions and monitoring, instead of becoming a signature sheet detached from the recommendation.
Combining purchaser and household burdens requires a named perspective. Staff time belongs in the institution’s resource estimate; patient travel might not appear in its ledger but still matters to the policy brief. A societal view can include resources used by both sides, with care to avoid double counting. A payment made by one organization to a provider is not automatically a second, equal resource cost. These distinctions do not settle the option ranking yet. They tell the analyst which data and stakeholder conversations are needed.
Ask each group a question it can actually answer. Ask patients about visits and travel time, not only whether they support the policy. Ask scheduling staff about minutes per call and repeat attempts, then compare their estimate with shift records if available. Ask the authorized official about budget and approval stages rather than clinical effectiveness. Record how participants were selected: five interviews can reveal a risk but cannot estimate its population prevalence. Where accounts conflict, identify the disputed claim and the record that could test it instead of automatically preferring the highest-ranking speaker.
A useful matrix ends with a “decision effect” column: a revised cost item, changed eligibility definition, safety review, or approval condition. If every row leaves it blank, the map may be a social description rather than an analytical aid. Before submitting the brief, let affected representatives check whether service burdens are portrayed fairly and let the responsible office check that authority has not been invented. Such review does not imply unanimous endorsement. The decision record can preserve reasoned disagreement beside its assumptions.
Lesson summary
Reference solution: 2.